SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Calamity Jane Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMartha Canary
Date of birth1856-05-01
IdentifiersMRN HR-NI008-SYN-TD; SSN (made up) 000-08-9532
Document date2026-11-01
AuthorRuth Ann Kessler, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for heavy daily drinking: a nonjudgmental, trauma-informed assessment, withdrawal risk and outpatient withdrawal management, thiamine, liver tests, nutrition, mood and safety, and housing, food and income. Concerns: She wants to stop drinking before it kills her, and does not want a lecture; She is afraid of the shakes if she stops, and has nowhere steady to stay; She is worried about her liver and her weight. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days onlyPer the written five-day scheduleOral route1901-03-02 to 1901-03-06completedS
Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic100 mg intramuscularly once daily for three daysIntramuscular route1901-03-02 to 1901-03-04completedS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-05activeS
Folic acid 1 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-02activeS
Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five daysOne tablet daily with food for five daysOral route1901-03-02 to 1901-03-06completedS
Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeksOne tablet twice daily for two weeksOral route1901-03-02 to 1901-03-16completedS
Naltrexone 50 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-09 to 1901-03-30completedS
Extended-release naltrexone 380 mg by deep intramuscular injection into the buttock every four weeks, given by the clinic nurse380 mg intramuscularly every four weeksIntramuscular route1901-03-30activeS
Amoxicillin 500 mg oral capsule, one capsule three times daily for five daysOne capsule three times daily for five daysOral route1901-03-23 to 1901-03-28completedS
Ibuprofen 400 mg oral tablet, one tablet with food every 8 hours as needed for tooth pain, for up to five daysOne tablet with food every 8 hours as needed, up to five daysOral route1901-03-23 to 1901-03-28completedS
Acetaminophen 500 mg oral tablet, one tablet every 6 hours as needed with the ibuprofen, no more than 2,000 mg a day, for up to five daysOne tablet every 6 hours as needed, no more than 2,000 mg a dayOral route1901-03-23 to 1901-03-28completedS

Procedures

ProcedureDatesStatusEvidence
Advance care planning conversation, about 16 minutes1901-04-27 to 1901-04-27completedS

Immunizations

DateVaccineStatusEvidence
1901-04-27Tdap vaccine; no tetanus booster she can recallcompletedS
1901-04-27Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intakecompletedS
1901-04-27Hepatitis A vaccine, adult, first of two dosescompletedS
1901-04-27Pneumococcal conjugate vaccine (PCV20)completedS
1901-06-22Hepatitis B vaccine (HepB-CpG), second of two dosescompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1866 to 1867Orphaned at about eleven after the deaths of both parents within a year; causes of death not recorded in the cited sourcesD (CLM-0002)
from 1876Heavy drinking reported from her twenties on, with arrests for intoxicationD (CLM-0009)
1882 and 1887Birth of a son who died soon after birth, and later of a daughterD (CLM-0011)
mid-1880sViolence by a partner reported in newspapers; recorded without detailD (CLM-0012)
February 1901An illness, nature not recorded, for which she was cared for at a county poor farm for a few daysD (CLM-0015)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She wants to stop drinking before it kills her, and does not want a lectureactiveS
She is afraid of the shakes if she stops, and has nowhere steady to stayactiveS
She is worried about her liver and her weightactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.8 on 1901-03-02; Hemoglobin [Mass/volume] in Blood 13.1 on 1901-06-22; MCV [Entitic mean volume] in Red Blood Cells by Automated count 95 on 1901-06-22; Platelets [#/volume] in Blood by Automated count 214 on 1901-06-22; Sodium [Moles/volume] in Serum or Plasma 139 on 1901-06-22; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1901-06-22; Creatinine [Mass/volume] in Serum or Plasma 0.66 on 1901-06-22; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1896)/1.73 sq M 111 on 1901-06-22; Glucose [Mass/volume] in Serum or Plasma 84 on 1901-06-22; Magnesium [Mass/volume] in Serum or Plasma 1.8 on 1901-03-09; Phosphate [Mass/volume] in Serum or Plasma 2.4 on 1901-03-02; Albumin [Mass/volume] in Serum or Plasma 3.9 on 1901-06-22; Bilirubin.total [Mass/volume] in Serum or Plasma 1.1 on 1901-03-02; INR in Platelet poor plasma by Coagulation assay 1 on 1901-03-02; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 1901-06-22; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 1901-06-22; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 58 on 1901-06-22; Folate [Mass/volume] in Serum or Plasma 3.2 on 1901-03-02; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 1901-03-02; Phosphatidylethanol [Mass/volume] in Blood 64 on 1901-06-22; Total score [AUDIT] 31 on 1901-03-02; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 1901-06-22; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 1901-06-22; PC-PTSD-5 score [PC-PTSD-5] 2 on 1901-03-02; Liver stiffness by US.transient elastography 6.8 on 1901-06-22; Cholesterol [Mass/volume] in Serum or Plasma 168 on 1901-04-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 72 on 1901-04-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 80 on 1901-04-27; Triglyceride [Mass/volume] in Serum or Plasma 82 on 1901-04-27 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis.
Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checksresolvedconfirmed F10.230S — Synthetic withdrawal episode; resolved by the one-week visit.
Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement plannedresolvedconfirmed R74.01S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease.
Alcohol-associated steatotic liver disease, without cirrhosis: liver stiffness 9.6 kPa after four weeks without alcohol, falling enzymes, normal bilirubin, albumin, INR and plateletsactiveconfirmed K70.0S — Synthetic modern diagnosis made at the four-week visit.
Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcoholresolvedprovisional F32.AS — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood.
Daily chewing tobacco for many years; not ready to stop at intakeactiveconfirmed F17.220S — Synthetic modern coding anchored to the documented chewing tobacco.
Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albuminactiveconfirmed R63.6S — Synthetic finding anchored to a contemporary impression of poor nutrition (R).
Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past wintersactiveconfirmed Z59.811S — Synthetic social need anchored to her documented poverty and moves from town to town.
Food insecurity: often goes without meals at the end of the monthactiveconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.
Periapical abscess of a lower left molar with facial swelling and low-grade fever, on naltrexone; treated without opioids, tooth removed at the dental clinic the next day; resolvedresolvedconfirmed K04.7S — Synthetic acute illness; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1901-03-02Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
1901-03-02Hemoglobin [Mass/volume] in Blood12.1g/dL12-15.5 g/dLNormalS
1901-03-02MCV [Entitic mean volume] in Red Blood Cells by Automated count103fL80-100 fLHighS
1901-03-02Platelets [#/volume] in Blood by Automated count16210*3/uL150-400 10*3/uLNormalS
1901-03-02Sodium [Moles/volume] in Serum or Plasma134mmol/L135-145 mmol/LLowS
1901-03-02Potassium [Moles/volume] in Serum or Plasma3.3mmol/L3.5-5.1 mmol/LLowS
1901-03-02Creatinine [Mass/volume] in Serum or Plasma0.62mg/dL0.59-1.04 mg/dLNormalS
1901-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1896)/1.73 sq M113mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1901-03-02Glucose [Mass/volume] in Serum or Plasma78mg/dL70-99 mg/dLNormalS
1901-03-02Magnesium [Mass/volume] in Serum or Plasma1.5mg/dL1.7-2.3 mg/dLLowS
1901-03-02Phosphate [Mass/volume] in Serum or Plasma2.4mg/dL2.5-4.5 mg/dLLowS
1901-03-02Albumin [Mass/volume] in Serum or Plasma3.4g/dL3.5-5 g/dLLowS
1901-03-02Bilirubin.total [Mass/volume] in Serum or Plasma1.1mg/dL<=1.2 mg/dLNormalS
1901-03-02INR in Platelet poor plasma by Coagulation assay1{INR}0.9-1.1NormalS
1901-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma96U/L10-35 U/LHighS
1901-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma44U/L7-35 U/LHighS
1901-03-02Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma240U/L5-40 U/LHighS
1901-03-02Folate [Mass/volume] in Serum or Plasma3.2ng/mL>=4 ng/mLLowS
1901-03-02Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL200-900 pg/mLNormalS
1901-03-02Phosphatidylethanol [Mass/volume] in Blood820ng/mL<=20 ng/mLHighS
1901-03-02Total score [AUDIT]31{score}S
1901-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
1901-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]11{score}S
1901-03-02PC-PTSD-5 score [PC-PTSD-5]2{score}S
1901-03-09Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
1901-03-09Magnesium [Mass/volume] in Serum or Plasma1.8mg/dL1.7-2.3 mg/dLNormalS
1901-03-30Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
1901-03-30MCV [Entitic mean volume] in Red Blood Cells by Automated count100fL80-100 fLNormalS
1901-03-30Platelets [#/volume] in Blood by Automated count19110*3/uL150-400 10*3/uLNormalS
1901-03-30Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma48U/L10-35 U/LHighS
1901-03-30Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L7-35 U/LNormalS
1901-03-30Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma132U/L5-40 U/LHighS
1901-03-30Albumin [Mass/volume] in Serum or Plasma3.6g/dL3.5-5 g/dLNormalS
1901-03-30Phosphatidylethanol [Mass/volume] in Blood24ng/mL<=20 ng/mLHighS
1901-03-30Liver stiffness by US.transient elastography9.6kPa<=8 kPaHighS
1901-03-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
1901-03-30Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S
1901-04-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
1901-05-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1901-05-11Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
1901-06-22Hemoglobin [Mass/volume] in Blood13.1g/dL12-15.5 g/dLNormalS
1901-06-22MCV [Entitic mean volume] in Red Blood Cells by Automated count95fL80-100 fLNormalS
1901-06-22Platelets [#/volume] in Blood by Automated count21410*3/uL150-400 10*3/uLNormalS
1901-06-22Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1901-06-22Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1901-06-22Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.59-1.04 mg/dLNormalS
1901-06-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1896)/1.73 sq M111mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1901-06-22Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
1901-06-22Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L10-35 U/LNormalS
1901-06-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-35 U/LNormalS
1901-06-22Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma58U/L5-40 U/LHighS
1901-06-22Albumin [Mass/volume] in Serum or Plasma3.9g/dL3.5-5 g/dLNormalS
1901-06-22Phosphatidylethanol [Mass/volume] in Blood64ng/mL<=20 ng/mLHighS
1901-06-22Liver stiffness by US.transient elastography6.8kPa<=8 kPaNormalS
1901-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1901-06-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
1901-04-27Cholesterol [Mass/volume] in Serum or Plasma168mg/dL<=199 mg/dLNormalS
1901-04-27Cholesterol in HDL [Mass/volume] in Serum or Plasma72mg/dL>=50 mg/dLNormalS
1901-04-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation80mg/dL<=99 mg/dLNormalS
1901-04-27Triglyceride [Mass/volume] in Serum or Plasma82mg/dL<=149 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1901-03-02Body height165cmS
1901-03-02Body weight50kgS
1901-03-02Body mass index (BMI) [Ratio]18.4kg/m2S
1901-03-02Systolic blood pressure146mm[Hg]S
1901-03-02Diastolic blood pressure92mm[Hg]S
1901-03-02Heart rate104/minS
1901-03-02Respiratory rate18/minS
1901-03-02Body temperature37.2CelS
1901-03-02Oxygen saturation in Arterial blood by Pulse oximetry97%S
1901-03-09Body height165cmS
1901-03-09Body weight50.4kgS
1901-03-09Body mass index (BMI) [Ratio]18.5kg/m2S
1901-03-09Systolic blood pressure128mm[Hg]S
1901-03-09Diastolic blood pressure82mm[Hg]S
1901-03-09Heart rate84/minS
1901-03-09Respiratory rate16/minS
1901-03-09Body temperature36.8CelS
1901-03-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1901-03-30Body height165cmS
1901-03-30Body weight50.9kgS
1901-03-30Body mass index (BMI) [Ratio]18.7kg/m2S
1901-03-30Systolic blood pressure122mm[Hg]S
1901-03-30Diastolic blood pressure78mm[Hg]S
1901-03-30Heart rate78/minS
1901-03-30Respiratory rate16/minS
1901-03-30Body temperature36.7CelS
1901-03-30Oxygen saturation in Arterial blood by Pulse oximetry98%S
1901-05-11Body height165cmS
1901-05-11Body weight51.8kgS
1901-05-11Body mass index (BMI) [Ratio]19kg/m2S
1901-05-11Systolic blood pressure118mm[Hg]S
1901-05-11Diastolic blood pressure76mm[Hg]S
1901-05-11Heart rate74/minS
1901-05-11Respiratory rate16/minS
1901-05-11Body temperature36.6CelS
1901-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
1901-06-22Body height165cmS
1901-06-22Body weight52.6kgS
1901-06-22Body mass index (BMI) [Ratio]19.3kg/m2S
1901-06-22Systolic blood pressure116mm[Hg]S
1901-06-22Diastolic blood pressure74mm[Hg]S
1901-06-22Heart rate72/minS
1901-06-22Respiratory rate16/minS
1901-06-22Body temperature36.6CelS
1901-06-22Oxygen saturation in Arterial blood by Pulse oximetry98%S
1901-04-27Body height165cmS
1901-04-27Body weight51.4kgS
1901-04-27Body mass index (BMI) [Ratio]18.9kg/m2S
1901-04-27Systolic blood pressure120mm[Hg]S
1901-04-27Diastolic blood pressure76mm[Hg]S
1901-04-27Heart rate76/minS
1901-04-27Respiratory rate16/minS
1901-04-27Body temperature36.6CelS
1901-04-27Oxygen saturation in Arterial blood by Pulse oximetry98%S
1901-03-23Body height165cmS
1901-03-23Body weight50.6kgS
1901-03-23Body mass index (BMI) [Ratio]18.6kg/m2S
1901-03-23Systolic blood pressure124mm[Hg]S
1901-03-23Diastolic blood pressure80mm[Hg]S
1901-03-23Heart rate92/minS
1901-03-23Respiratory rate16/minS
1901-03-23Body temperature38.1CelS
1901-03-23Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1901-03-02Establishing primary care for heavy daily drinking: a nonjudgmental, trauma-informed assessment, withdrawal risk and outpatient withdrawal management, thiamine, liver tests, nutrition, mood and safety, and housing, food and incomefinishedS
1901-03-09One-week review, seen the same day by addiction medicine: after withdrawal, a medicine for alcohol use disorder, the liver plan and recovery supportsfinishedS
1901-03-30Four-week review: naltrexone and the change to a monthly injection, liver stiffness, mood after four weeks without alcohol, and benefitsfinishedS
1901-05-11Ten-week review: recovery, mood, housing and resultsfinishedS
1901-06-22Sixteen-week review after a two-day return to drinking: liver tests, PEth, elastography and the plan aheadfinishedS
1901-04-27Periodic adult preventive visitfinishedS
1901-03-23Same-day sick visit for a dental abscessfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
A nonjudgmental, trauma-informed assessment: AUDIT, DSM-5-TR criteria and PEth explained as part of care, person-first language, a female clinician and a chaperone offered, consent asked before each part of the examination, and her own goals and choices firstcompletedGL-NIAAA-CORE, GL-APA-AUD-2018, GL-USPSTF-ALC-2018S
Addiction medicine consultation to confirm the diagnosis, review withdrawal and choose a medicine for alcohol use disordercompletedGL-APA-AUD-2018, GL-ASAM-AWM-2020S
Outpatient withdrawal management at low risk (PAWSS 3, CIWA-Ar 9): a five-day gabapentin schedule, daily nurse checks with the CIWA-Ar in person or by the clinic phone, her friend as support, fluids and food; hospital care at once for a CIWA-Ar of 15 or more, a seizure, hallucinations, confusion or vomitingcompletedGL-ASAM-AWM-2020S
Thiamine 100 mg by injection for three days, then by mouth, with folic acid, potassium and magnesium replacementcompletedGL-ASAM-AWM-2020, GL-AASLD-ALD-2019S
Medicine for alcohol use disorder: naltrexone 50 mg daily, with a monthly extended-release naltrexone injection if daily tablets are hard to keep; liver tests rechecked on treatment; acamprosate if naltrexone cannot be used; disulfiram not used; a wallet card explaining that naltrexone blocks opioid pain medicinescompletedGL-APA-AUD-2018, GL-NIAAA-CORES
Liver: FIB-4 of 3.93, so transient elastography; liver enzymes, albumin, INR and platelets followed; hepatitis A and B vaccination; acetaminophen no more than 2 g a daycompletedGL-AASLD-ALD-2019S
Mood and safety: PHQ-9 and GAD-7 again after two to four weeks without alcohol before deciding on depression treatment; a structured safety assessment, a written safety plan, the rifle stored with her friend, the 988 Suicide & Crisis Lifeline, and safety review at every visitcompletedGL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024, GL-APA-AUD-2018S
Recovery support and harm reduction: weekly contact with the clinic's peer recovery support specialist, her choice of mutual-help meetings (Alcoholics Anonymous, SMART Recovery or Women for Sobriety), and a plan for a return to drinking: call the peer specialist or the clinic, eat, do not drink alone or drive, keep taking any medicine for alcohol use disorder, and come back without shamecompletedGL-NIAAA-CORE, GL-APA-AUD-2018S
Housing, food, income and coverage: the clinic's community health worker helps with a Montana Medicaid application, SNAP benefits, a food bank, the local Human Resource Development Council's housing programs, Montana 211, and a free phone through the Lifeline programcompletedGL-NIAAA-CORES
Alcohol and women's health: why the same amount of alcohol does women more harm (higher blood alcohol, faster liver damage, a higher breast cancer risk), a pregnancy test, contraception if needed, and breast and cervical cancer screening at the preventive visitcompletedGL-NIAAA-CORES
Chewing tobacco: advice to stop and nicotine replacement offered whenever she is readycompletedGL-USPSTF-TOB-2021S

Goals

GoalTargetStatusOutcomeProvenance
Finish withdrawal safely at home without a seizure or delirium1901-03-09completedFive days of gabapentin with daily nurse checks; CIWA-Ar 9 at intake, 10 at most, 2 at one week; no seizure, hallucinations or confusionS
No drinking, her goal, with a medicine for alcohol use disorder1901-06-22activeNo alcohol for twelve weeks, then two days of drinking in late May, followed by three weeks without; PEth 820 to 24, then 64 after the lapseS
Liver tests back to normal and a clear answer on liver scarring1901-06-22completedAST 96 to 31 and ALT 44 to 24 U/L; liver stiffness 9.6 to 6.8 kPa; no advanced fibrosisS
Regular meals and a healthier weight1901-06-22activeWeight 50.0 to 52.6 kg (BMI 18.4 to 19.3); SNAP benefits and two meals a day on most daysS
A room of her own and health coverage1901-06-22completedMedicaid approved by the four-week visit; a rented room through a housing program by the ten-week visitS
PHQ-9 below 10, and reassessment once she has stopped drinking1901-05-11completedPHQ-9 14 to 5 after ten weeks without alcoholS

Functional Status

Mental Status

Structured synthetic safety assessment on 1901-03-02: current ideation absent, intent absent, plan absent. Outpatient care with daily nurse checks during withdrawal and close follow-up. Risk factors reviewed without detail: severe alcohol use disorder, depressive symptoms, early losses, past violence by a partner, housing instability and living alone at times. Firearm safety was discussed: she agreed to leave her rifle, unloaded, with her friend, who keeps it locked, during the first months of recovery. A written safety plan was made with her, and the 988 Suicide & Crisis Lifeline (call or text 988) was written on the card she carries, since she has no phone. Safety is reviewed at every visit [S]